A Study of the First-line Treatment of Patients With Newly Diagnosed Transplant-ineligible Multiple Myeloma in Spain

CompletedOBSERVATIONAL
Enrollment

706

Participants

Timeline

Start Date

July 19, 2018

Primary Completion Date

January 18, 2019

Study Completion Date

January 18, 2019

Conditions
Multiple Myeloma
Trial Locations (20)

11408

H. Jerez, Jerez de la Frontera

15706

H. Santiago (CHUS), Santiago de Compostela

17007

H. Josep Trueta, Girona

25198

H. Arnau de Villanova, Lleida

29010

H- Virgen de la Victoria, Málaga

H. Carlos Haya, Málaga

32005

H. Ourense (CHOU), Ourense

33011

H. Central de Asturias, Oviedo

33394

H. Cabueñes, Gijón

36312

H. Alvaro Cunqueiro, Vigo

41009

H. Virgen Macarena, Seville

43005

H. Joan XXIII, Tarragona

46017

H. Dr. Peset, Valencia

46026

H. La Fe, Valencia

01009

H. Txagorritxu, Vitoria-Gasteiz

07120

H. Son Espases, Palma

08908

ICO Duran i Reynals, L'Hospitalet de Llobregat

08243

H. Althaia, Manresa

08221

H. Mutua de Terrassa, Terrassa

0 8003

H. del Mar, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Celgene

INDUSTRY